RNA editing is the next frontier in gene therapy – here’s what you need to know
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. This trial marks a new (...)
Site référencé: Raw Story
Raw Story
MAGA rep busted after story on office sleepovers curiously changes
12/08/2025
Trump’s BLS pick blasted by conservative outlet : ‘Willful misinterpretation or ignorance’
12/08/2025
'He ran on lies !' Trump voter turns on MAGA after being wrestled to the ground by ICE
12/08/2025
Jeanine Pirro trashes ‘yoga rehab’ for criminals as Maxwell lands in posh prison with yoga
12/08/2025
Texas Senate approves new congressional lines as House Democrats remain out of state
12/08/2025
Karoline Leavitt won't rule out Medal of Freedom for ex-DOGE staffer 'Big Balls'
12/08/2025
